Skip to main content
TipRanks
Go Ultimate75% OFF

John C. Martin Insider Profile

25 Followers

John C. Martin, Director at Sarepta Therapeutics, holds 7.91K shares in Sarepta Therapeutics (Ticker: SRPT), holds 1.95M shares in Kronos Bio (Ticker: KRON), holds 2.89M shares in Gilead Sciences (Ticker: GILD).

John C. Martin's Trading History

SRPT
Sarepta Therapeutics
Mar 05, 2021DirectorUninformative Buy―$127.16K
KRON
Kronos Bio
Oct 16, 2020―Informative Buy3.31M$1.72M
GILD
Gilead Sciences
Feb 08, 2019DirectorUninformative Buy―$485.28M

You May Also Like

John C. Martin insider profile FAQ

What is the percentage of profitable transactions made by John C. Martin?
The percentage of profitable transactions made by John C. Martin is 60%.
What is the average return per transaction made by John C. Martin?
The average return per transaction made by John C. Martin is 0.70%.
What stocks does John C. Martin hold?
John C. Martin holds: SRPT, GILD, KRON stocks.
What was John C. Martin's most profitable transaction?
John C. Martin’s most profitable transaction was an Informative Sell of GILD stock on November 4, 2015. The return on the trade was 32.10%.
What is John C. Martin's role in Sarepta Therapeutics?
John C. Martin's role in Sarepta Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.